Table 1.

Literature of primary minimal-invasive/endovascular therapy of mycotic aneurysms in pediatric patients.

	No. of patients	Type of pathology	Type of stent
Gupta et al. (16)	1	Mycotic intracavernous carotid artery aneurysm secondary to post-infective cavernous sinus thrombosis	3.5 mm × 27 mm Aneugraft PCS (ITGI Medical, OR Akiva, Israel)
Quinney et al. (17)	1	Mycotic ascending aortic aneurysm after pericarditis from methicillin-sensitive Staphylococcus aureus and attempted surgical repair	26 × 10 Gore TAG (W.L. Gore & Associates, USA) across the aortic arch; 11 × 5 Viabahn (W.L. Gore & Associates, USA) & 10 × 37 ICAST (Atrium Medical, USA) in the innominate artery
Skrabonja-Crespo et al. (18)	1	Ascending aortic pseudoaneurysm after heart transplantation and methicillin-sensitive S. aureus sepsis	45 mm Covered CP Stent™ (B. Braun Interventional Systems Inc., USA)
Srivastava et al. (19)	1	Infected pseudoaneurysm of a modified Blalock-Taussig shunt	6 mm × 38 mm Advanta V12 (Atrium Medical, USA)
Sunil et al. (7)	1	Mycotic iliac aneurysm with a history of infective endocarditis	7 mm × 58 mm Lifestream BE stent-graft (Becton Dickinson, UK)
Tomar et al. (20)	1	Mycotic aortic aneurysm after coarctation repair	16-20-93 Endurant II Limb Extension stent graft, (Medtronic, USA)

Literature on primary minimally invasive/endovascular therapy of mycotic aneurysms in pediatric patients.